NEW YORK (GenomeWeb News) – Coastal Genomics announced that it has licensed from the BC Cancer Agency exclusive rights to a liquid handling automation technology.

The Vancouver, British Columbia-based firm said that the technology would be marketed as the Ranger automated workstation. The system, the company said, will be able to completely automate the process of agarose gel size selection of DNA fragments for between one and 96 samples in a single run.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.